SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-19-039951
Filing Date
2019-07-11
Accepted
2019-07-11 16:23:51
Documents
6
Effectiveness Date
2019-07-11

Document Format Files

Seq Description Document Type Size
1 S-8 a19-12724_2s8.htm S-8 92103
2 EX-5.1 a19-12724_2ex5d1.htm EX-5.1 10517
3 EX-23.1 a19-12724_2ex23d1.htm EX-23.1 2538
4 GRAPHIC g127242kii001.gif GRAPHIC 2603
5 GRAPHIC g127242kii002.gif GRAPHIC 644
6 GRAPHIC g127242kii003.gif GRAPHIC 503
  Complete submission text file 0001104659-19-039951.txt   111659
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232610 | Film No.: 19951384
SIC: 2836 Biological Products, (No Diagnostic Substances)